Literature DB >> 1670959

Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4.

H Cen1, M C Breinig, R W Atchison, M Ho, J L McKnight.   

Abstract

Two organ transplant recipients who received organs from a common donor and were diagnosed as having an Epstein-Barr virus (EBV)-associated posttransplant lymphoproliferative disorder were studied to determine the mode of EBV transmission. The results of restriction fragment length polymorphism, polymerase chain reaction, and minisatellite DNA analyses demonstrate that both patients had a common strain of EBV and that this strain was transmitted from the donor's organs to both recipients. Posttransplant lymphoproliferative disorder resulted from the proliferation of EBV-immortalized B lymphocytes of the recipient, not those of the donor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1670959      PMCID: PMC239842     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study.

Authors:  G de-Thé; A Geser; N E Day; P M Tukei; E H Williams; D P Beri; P G Smith; A G Dean; G W Bronkamm; P Feorino; W Henle
Journal:  Nature       Date:  1978-08-24       Impact factor: 49.962

2.  Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

Authors:  T E Starzl; M A Nalesnik; K A Porter; M Ho; S Iwatsuki; B P Griffith; J T Rosenthal; T R Hakala; B W Shaw; R L Hardesty
Journal:  Lancet       Date:  1984-03-17       Impact factor: 79.321

3.  The transplanted kidney as a source of cytomegalovirus infection.

Authors:  M Ho; S Suwansirikul; J N Dowling; L A Youngblood; J A Armstrong
Journal:  N Engl J Med       Date:  1975-11-27       Impact factor: 91.245

4.  The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation.

Authors:  N Raab-Traub; K Flynn
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

5.  Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients.

Authors:  J W Gratama; M A Oosterveer; J M Lepoutre; J J van Rood; F E Zwaan; J M Vossen; J G Kapsenberg; D Richel; G Klein; I Ernberg
Journal:  Transplantation       Date:  1990-04       Impact factor: 4.939

6.  Epstein-Barr virus lymphoproliferation after bone marrow transplantation.

Authors:  M M Zutter; P J Martin; G E Sale; H M Shulman; L Fisher; E D Thomas; D M Durnam
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

7.  The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.

Authors:  M A Nalesnik; R Jaffe; T E Starzl; A J Demetris; K Porter; J A Burnham; L Makowka; M Ho; J Locker
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

8.  Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency.

Authors:  J W Gratama; M A Oosterveer; F E Zwaan; J Lepoutre; G Klein; I Ernberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

9.  Quantitative evaluation of Epstein-Barr-virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis.

Authors:  G Rocchi; A Felici; G Ragona; A Heinz
Journal:  N Engl J Med       Date:  1977-01-20       Impact factor: 91.245

10.  The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children.

Authors:  M Ho; R Jaffe; G Miller; M K Breinig; J S Dummer; L Makowka; R W Atchison; F Karrer; M A Nalesnik; T E Starzl
Journal:  Transplantation       Date:  1988-04       Impact factor: 4.939

View more
  22 in total

Review 1.  The role of EBV in post-transplant malignancies: a review.

Authors:  P Hopwood; D H Crawford
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

2.  Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia.

Authors:  D M Walling; S N Edmiston; J W Sixbey; M Abdel-Hamid; L Resnick; N Raab-Traub
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

Review 3.  Lymphoproliferative disease in organ transplant recipients.

Authors:  M A Nalesnik
Journal:  Springer Semin Immunopathol       Date:  1991

Review 4.  Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.

Authors:  R J O'Reilly; T N Small; E Papadopoulos; K Lucas; J Lacerda; L Koulova
Journal:  Springer Semin Immunopathol       Date:  1998

Review 5.  Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders.

Authors:  T Haque; D H Crawford
Journal:  Springer Semin Immunopathol       Date:  1998

6.  Adenovirus infection in pediatric liver transplant recipients.

Authors:  M G Michaels; M Green; E R Wald; T E Starzl
Journal:  J Infect Dis       Date:  1992-01       Impact factor: 5.226

Review 7.  Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.

Authors:  M A Nalesnik; T E Starzl
Journal:  Transplant Sci       Date:  1994-09

8.  Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia.

Authors:  D M Walling; N Raab-Traub
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Screening donors for xenotransplantation. The potential for xenozoonoses.

Authors:  M G Michaels; J P McMichael; K Brasky; S Kalter; R L Peters; T E Starzl; R L Simmons
Journal:  Transplantation       Date:  1994-05-27       Impact factor: 4.939

10.  Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatment.

Authors:  Upton Allen; Caroline Alfieri; Jutta Preiksaitis; Atul Humar; Dorothy Moore; Bruce Tapiero; Raymond Tellier; Michael Green; Dele Davies; Diane Hébert; Sheila Weitzman; Martin Petric; Kevan Jacobson
Journal:  Can J Infect Dis       Date:  2002-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.